Foreign executives annual salary has been nearly 100 million yuan, while the salaries of Chinese executives are still mainly concentrated in the million-dollar range.
Some key positions are also well paid, with the director of the product delivery center receiving a salary of 480,000 yuan, the head of finance receiving a salary of 470,000 yuan, and four core technicians receiving an annual salary of more than 240,000 yuan, with one of the core technicians receiving an annual salary of millions of yuan.In 2017, the total remuneration of key executives amounted to 4,454,800 yuan, and rose to 8,392,000 yuan in 2019, with the executives' overall pay has risen significantly.
In the salary structure of the executives, the independent directors are entitled to the independent director allowance, which is determined by the company with reference to the general level of independent director remuneration in the capital market.
No other benefits are provided. Other directors and supervisors are not entitled to separate director's and supervisor's allowances, and outside directors and supervisors are not entitled to other remuneration and benefits. In addition to the above, directors, supervisors, senior management and core technical personnel receive employee remuneration from the Company, which mainly consists of fixed salaries and performance bonuses.
Kangtai Medicine, headquartered in Qinhuangdao, Hebei province, was also listed on the GEM board last year, with Hu Kun, chairman of Kangtai Medicine, receiving a salary of 252,000 yuan, a director of 207,400 yuan and a general manager of 243,300 yuan, according to the prospectus. Kangtai Medicine's total executive compensation reached 3.2248 million yuan in 2017, rising to 3.2766 million yuan in 2019, a modest increase.
While the executives receive a low salary, but they all hold a lot of shares, as of the date of the prospectus, the chairman of Kangtai medicine Hu Kun shareholding reached 52%, other executives such as deputy general manager, chief financial officer, deputy director of the research and development center also hold a certain number of shares.